Award
National Cancer Institute 3U01CA279858-04S1
Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach
Recipient
Massachusetts General Hospital
Award Amount
$124,465.00
Ceiling
$124,465.00
Awarded
August 05, 2026
Identifier
3U01CA279858-04S1
Award for developing a portable cervical cancer screening platform using CRISPR technology, funded by NIH and involving Massachusetts General Hospital and National Cancer Institute.
Description
This project aims to develop a portable platform for cervical cancer screening using CRISPR technology, with a focus on low-resource settings in Uganda and Ghana. The project is funded by the NIH and involves collaboration between Massachusetts General Hospital and the National Cancer Institute.